-
1
-
-
9744226667
-
Trends in prescribing of selective serotonin-reuptake inhibitors and other newer antidepressant agents in adult primary care. (Primary Care Companion)
-
Pirraglia PA, Stafford RS, Singer DE: Trends in prescribing of selective serotonin-reuptake inhibitors and other newer antidepressant agents in adult primary care. (Primary Care Companion) J Clin Psychiatry 2003; 5:153-157
-
(2003)
J Clin Psychiatry
, vol.5
, pp. 153-157
-
-
Pirraglia, P.A.1
Stafford, R.S.2
Singer, D.E.3
-
3
-
-
1542316301
-
Cyclic antidepressants and the risk of sudden cardiac death
-
Ray WA, Meredith S, Thapa PB, et al: Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004; 75:234-241
-
(2004)
Clin Pharmacol Ther
, vol.75
, pp. 234-241
-
-
Ray, W.A.1
Meredith, S.2
Thapa, P.B.3
-
4
-
-
0028946692
-
Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs
-
Spigset O, Hedenmalm K: Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Saf 1995; 12:209-225
-
(1995)
Drug Saf
, vol.12
, pp. 209-225
-
-
Spigset, O.1
Hedenmalm, K.2
-
5
-
-
0029843155
-
Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin-reuptake inhibitors: A review of spontaneous reports
-
Liu BA, Mittmann N, Knowles SR, et al: Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin-reuptake inhibitors: a review of spontaneous reports. CMAJ 1996; 155:519-527
-
(1996)
CMAJ
, vol.155
, pp. 519-527
-
-
Liu, B.A.1
Mittmann, N.2
Knowles, S.R.3
-
7
-
-
0031984133
-
Incidence of selective serotonin-reuptake inhibitor (SSRI)-induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly
-
Bouman WP, Pinner G, Johnson H: Incidence of selective serotonin-reuptake inhibitor (SSRI)-induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly. Int J Geriatr Psychiatry 1998; 13:12-15
-
(1998)
Int J Geriatr Psychiatry
, vol.13
, pp. 12-15
-
-
Bouman, W.P.1
Pinner, G.2
Johnson, H.3
-
8
-
-
10744232653
-
Paroxetine-induced hyponatremia in older adults: A 12-week prospective study
-
Fabian TJ, Amico JA, Kroboth PD, et al: Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Arch Intern Med 2004; 164:327-332
-
(2004)
Arch Intern Med
, vol.164
, pp. 327-332
-
-
Fabian, T.J.1
Amico, J.A.2
Kroboth, P.D.3
-
9
-
-
0035020354
-
Hyponatraemia and selective serotonin-reuptake inhibitors in elderly patients
-
Kirby D, Ames D: Hyponatraemia and selective serotonin-reuptake inhibitors in elderly patients. Int J Geriatr Psychiatry 2001; 16:484-493
-
(2001)
Int J Geriatr Psychiatry
, vol.16
, pp. 484-493
-
-
Kirby, D.1
Ames, D.2
-
10
-
-
0025696013
-
The management of symptomatic hyponatremia
-
Sterns RH: The management of symptomatic hyponatremia. Semin Nephrol 1990; 10:503-514
-
(1990)
Semin Nephrol
, vol.10
, pp. 503-514
-
-
Sterns, R.H.1
-
11
-
-
0027212698
-
Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter
-
Lesch KP, Wolozin BL, Murphy DL, et al: Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 1993; 60:2319-2322
-
(1993)
J Neurochem
, vol.60
, pp. 2319-2322
-
-
Lesch, K.P.1
Wolozin, B.L.2
Murphy, D.L.3
-
12
-
-
0033736177
-
Paroxetine decreases platelet serotonin storage and platelet function in human beings
-
Hergovich N, Aigner M, Eichler HG, et al: Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 2000; 68:435-442
-
(2000)
Clin Pharmacol Ther
, vol.68
, pp. 435-442
-
-
Hergovich, N.1
Aigner, M.2
Eichler, H.G.3
-
13
-
-
0026566868
-
Bleeding, a side effect of fluoxetine (letter)
-
Aranth J, Lindberg C: Bleeding, a side effect of fluoxetine (letter). Am J Psychiatry 1992; 149:412
-
(1992)
Am J Psychiatry
, vol.149
, pp. 412
-
-
Aranth, J.1
Lindberg, C.2
-
14
-
-
0030281668
-
Fluvoxarnine-associated bleeding
-
Leung M, Shore R: Fluvoxarnine-associated bleeding. Can J Psychiatry 1996; 41:604-605
-
(1996)
Can J Psychiatry
, vol.41
, pp. 604-605
-
-
Leung, M.1
Shore, R.2
-
16
-
-
0030008115
-
Subhyaloid haemorrhage with fluoxetine
-
Wilmshurst PT, Kumar AV: Subhyaloid haemorrhage with fluoxetine. Eye 1996; 10 (Pt 1):141
-
(1996)
Eye
, vol.10
, Issue.PART 1
, pp. 141
-
-
Wilmshurst, P.T.1
Kumar, A.V.2
-
17
-
-
0032005912
-
Spontaneous ecchymoses due to paroxetine administration
-
Cooper TA, Valcour VG, Gibbons RB, et al: Spontaneous ecchymoses due to paroxetine administration. Am J Med 1998; 104:197-198
-
(1998)
Am J Med
, vol.104
, pp. 197-198
-
-
Cooper, T.A.1
Valcour, V.G.2
Gibbons, R.B.3
-
18
-
-
0033598594
-
Association between selective serotonin reuptake-inhibitors and upper gastrointestinal bleeding: Population-based, case-control study
-
de Abajo FJ, Rodriguez LA, Montero D: Association between selective serotonin reuptake-inhibitors and upper gastrointestinal bleeding: population-based, case-control study. BMJ 1999; 319(7217):1106-1109
-
(1999)
BMJ
, vol.319
, Issue.7217
, pp. 1106-1109
-
-
de Abajo, F.J.1
Rodriguez, L.A.2
Montero, D.3
-
19
-
-
13744265417
-
Use of selective serotonin reuptake-inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study
-
Dalton SO, Johansen C, Mellemkjaer L, et al: Use of selective serotonin reuptake-inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003; 163:59-64
-
(2003)
Arch Intern Med
, vol.163
, pp. 59-64
-
-
Dalton, S.O.1
Johansen, C.2
Mellemkjaer, L.3
-
20
-
-
15844407976
-
General population-based study of the impact of tricyclic and selective serotonin-reuptake inhibitor antidepressants on the risk of acute myocardial infarction
-
Tata LJ, West J, Smith C, et al: General population-based study of the impact of tricyclic and selective serotonin-reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 2005; 91:465-471
-
(2005)
Heart
, vol.91
, pp. 465-471
-
-
Tata, L.J.1
West, J.2
Smith, C.3
-
21
-
-
0035934609
-
Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: Retrospective cohort study
-
van Walraven C, Mamdani MM, Wells PS, et al: Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001; 323(7314):655-658
-
(2001)
BMJ
, vol.323
, Issue.7314
, pp. 655-658
-
-
van Walraven, C.1
Mamdani, M.M.2
Wells, P.S.3
-
22
-
-
33645046396
-
Increased use of selective serotonin-reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: A multicentre retrospective analysis
-
Wessinger S, Kaplan M, Choi L, et al: Increased use of selective serotonin-reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 2006; 23:937-944
-
(2006)
Aliment Pharmacol Ther
, vol.23
, pp. 937-944
-
-
Wessinger, S.1
Kaplan, M.2
Choi, L.3
-
23
-
-
27944496050
-
Antidepressants, warfarin, and the risk of hemorrhage
-
Kurdyak PA, Juurlink DN, Kopp A, et al: Antidepressants, warfarin, and the risk of hemorrhage. J Clin Psychopharmacol 2005; 25:561-564
-
(2005)
J Clin Psychopharmacol
, vol.25
, pp. 561-564
-
-
Kurdyak, P.A.1
Juurlink, D.N.2
Kopp, A.3
-
24
-
-
8844233380
-
Association of risk of abnormal bleeding with degree of serotonin-reuptake inhibition by antidepressants
-
Meijer WE, Heerdink ER, Nolen WA, et al: Association of risk of abnormal bleeding with degree of serotonin-reuptake inhibition by antidepressants. Arch Intern Med 2004; 164:2367-2370
-
(2004)
Arch Intern Med
, vol.164
, pp. 2367-2370
-
-
Meijer, W.E.1
Heerdink, E.R.2
Nolen, W.A.3
-
25
-
-
0036278007
-
Selective serotonin-reuptake inhibitors and the risk of stroke: A population-based case-control study
-
Bak S, Tsiropoulos I, Kjaersgaard JO, et al: Selective serotonin-reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 2002; 33:1465-1473
-
(2002)
Stroke
, vol.33
, pp. 1465-1473
-
-
Bak, S.1
Tsiropoulos, I.2
Kjaersgaard, J.O.3
-
26
-
-
0034131180
-
Intracranial haemorrhage and use of selective serotonin reuptake inhibitors
-
de Abajo FJ, Jick H, Derby L, et al: Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 2000; 50:43-47
-
(2000)
Br J Clin Pharmacol
, vol.50
, pp. 43-47
-
-
de Abajo, F.J.1
Jick, H.2
Derby, L.3
-
27
-
-
0142181146
-
Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients
-
Movig KL, Janssen MW, de Waal-Malefijt J, et al: Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 2003; 163:2354-2358
-
(2003)
Arch Intern Med
, vol.163
, pp. 2354-2358
-
-
Movig, K.L.1
Janssen, M.W.2
de Waal-Malefijt, J.3
-
28
-
-
1342328631
-
A critical review of selective serotonin-reuptake inhibitor-associated bleeding: Balancing the risk of treating hepatitis C-infected patients
-
Weinrieb RM, Auriacombe M, Lynch KG, et al: A critical review of selective serotonin-reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients. J Clin Psychiatry 2003; 64:1502-1510
-
(2003)
J Clin Psychiatry
, vol.64
, pp. 1502-1510
-
-
Weinrieb, R.M.1
Auriacombe, M.2
Lynch, K.G.3
-
30
-
-
0025869797
-
The serotonin syndrome
-
Sternbach H: The serotonin syndrome. Am J Psychiatry 1991; 148:705-713
-
(1991)
Am J Psychiatry
, vol.148
, pp. 705-713
-
-
Sternbach, H.1
-
31
-
-
0032720804
-
Antidepressants and the serotonin syndrome in general practice
-
Mackay FJ, Dunn NR, Mann RD: Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999; 49(448):871-874
-
(1999)
Br J Gen Pract
, vol.49
, Issue.448
, pp. 871-874
-
-
Mackay, F.J.1
Dunn, N.R.2
Mann, R.D.3
-
32
-
-
4444284449
-
Relative toxicity of selective serotonin-reuptake inhibitors (SSRIs) in overdose
-
Isbister GK, Bowe SJ, Dawson A, et al: Relative toxicity of selective serotonin-reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004; 42:277-285
-
(2004)
J Toxicol Clin Toxicol
, vol.42
, pp. 277-285
-
-
Isbister, G.K.1
Bowe, S.J.2
Dawson, A.3
-
33
-
-
15044361698
-
The serotonin syndrome
-
Boyer EW, Shannon M: The serotonin syndrome. N Engl J Med 2005; 352:1112-1120
-
(2005)
N Engl J Med
, vol.352
, pp. 1112-1120
-
-
Boyer, E.W.1
Shannon, M.2
-
34
-
-
0141786960
-
Serotonin syndrome and other serotonergic disorders
-
Ener RA, Meglathery SB, Van Decker WA, et al: Serotonin syndrome and other serotonergic disorders. Pain Med 2003; 4:63-74
-
(2003)
Pain Med
, vol.4
, pp. 63-74
-
-
Ener, R.A.1
Meglathery, S.B.2
Van Decker, W.A.3
-
35
-
-
32344446421
-
Interaction of serotonergic antidepressants and opioid analgesics: Is serotonin syndrome going undetected?
-
Gnanadesigan N, Espinoza RT, Smith R, et al: Interaction of serotonergic antidepressants and opioid analgesics: is serotonin syndrome going undetected? J Am Med Dir Assoc 2005; 6:265-269
-
(2005)
J Am Med Dir Assoc
, vol.6
, pp. 265-269
-
-
Gnanadesigan, N.1
Espinoza, R.T.2
Smith, R.3
-
36
-
-
0029739769
-
Serotonin syndrome complicating migraine pharmacotherapy
-
Mathew NT, Tietjen GE, Lucker C: Serotonin syndrome complicating migraine pharmacotherapy. Cephalalgia 1996; 16:323-327
-
(1996)
Cephalalgia
, vol.16
, pp. 323-327
-
-
Mathew, N.T.1
Tietjen, G.E.2
Lucker, C.3
-
37
-
-
29244474918
-
A case of serotonin syndrome precipitated by abuse of the anti-cough remedy dextromethorphan in a bipolar patient treated with fluoxetine and lithium
-
Navarro A, Perry C, Bobo WV: A case of serotonin syndrome precipitated by abuse of the anti-cough remedy dextromethorphan in a bipolar patient treated with fluoxetine and lithium. Gen Hosp Psychiatry 2006; 28:78-80
-
(2006)
Gen Hosp Psychiatry
, vol.28
, pp. 78-80
-
-
Navarro, A.1
Perry, C.2
Bobo, W.V.3
-
38
-
-
0034620261
-
Herb-drug interactions
-
Fugh-Berman A: Herb-drug interactions. Lancet 2000; 355(9198):134-138
-
(2000)
Lancet
, vol.355
, Issue.9198
, pp. 134-138
-
-
Fugh-Berman, A.1
-
39
-
-
2642533709
-
Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine
-
Gahlinger PM: Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine. Am Fam Physician 2004; 69:2619-2626
-
(2004)
Am Fam Physician
, vol.69
, pp. 2619-2626
-
-
Gahlinger, P.M.1
-
40
-
-
0033796137
-
An exploratory approach to the serotonin syndrome: An update of clinical phenomenology and revised diagnostic criteria
-
Radomski JW, Dursun SM, Reveley MA, et al: An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 2000; 55:218-224
-
(2000)
Med Hypotheses
, vol.55
, pp. 218-224
-
-
Radomski, J.W.1
Dursun, S.M.2
Reveley, M.A.3
-
42
-
-
0030862983
-
Serotonin syndrome, a clinical update
-
Mills KC: Serotonin syndrome, a clinical update. Crit Care Clin 1997; 13:763-783
-
(1997)
Crit Care Clin
, vol.13
, pp. 763-783
-
-
Mills, K.C.1
-
43
-
-
0042377403
-
The Hunter Serotonin Toxicity Criteria: Simple and accurate diagnostic decision rules for serotonin toxicity
-
Dunkley EJ, Isbister GK, Sibbritt D, et al: The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96:635-642
-
(2003)
QJM
, vol.96
, pp. 635-642
-
-
Dunkley, E.J.1
Isbister, G.K.2
Sibbritt, D.3
-
44
-
-
0030055191
-
Toxic serotonin syndrome or neuroleptic malignant syndrome?
-
Fink M: Toxic serotonin syndrome or neuroleptic malignant syndrome? Pharmacopsychiatry 1996; 29:159-161
-
(1996)
Pharmacopsychiatry
, vol.29
, pp. 159-161
-
-
Fink, M.1
-
45
-
-
0029988896
-
Serotonin-dopamine interaction and its relevance to schizophrenia
-
Kapur S, Remington G: Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1996; 153:466-476
-
(1996)
Am J Psychiatry
, vol.153
, pp. 466-476
-
-
Kapur, S.1
Remington, G.2
-
46
-
-
4344715163
-
Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: A randomized, double-blind, placebo-controlled discontinuation study
-
Montgomery SA, Kennedy SH, Burrows GD, et al: Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study. Int Clin Psychopharmacol 2004; 19:271-280
-
(2004)
Int Clin Psychopharmacol
, vol.19
, pp. 271-280
-
-
Montgomery, S.A.1
Kennedy, S.H.2
Burrows, G.D.3
-
47
-
-
0020041697
-
Recurrence of depression after discontinuation of long-term amitriptyline treatment
-
Bialos D, Giller E, Jatlow P, et al: Recurrence of depression after discontinuation of long-term amitriptyline treatment. Am J Psychiatry 1982; 139:325-329
-
(1982)
Am J Psychiatry
, vol.139
, pp. 325-329
-
-
Bialos, D.1
Giller, E.2
Jatlow, P.3
-
48
-
-
0001137855
-
Withdrawal symptoms following dicontinuation of imipramine therapy
-
Kramer JC, Klein DF, Fink M: Withdrawal symptoms following dicontinuation of imipramine therapy. Am J Psychiatry 1961; 118:549-550
-
(1961)
Am J Psychiatry
, vol.118
, pp. 549-550
-
-
Kramer, J.C.1
Klein, D.F.2
Fink, M.3
-
49
-
-
0021676596
-
Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists
-
Reid JL, Campbell BC, Hamilton CA: Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists. Hypertension 1984; 6(5 Pt 2):1171-1175
-
(1984)
Hypertension
, vol.6
, Issue.5 PART 2
, pp. 1171-1175
-
-
Reid, J.L.1
Campbell, B.C.2
Hamilton, C.A.3
-
50
-
-
0018382160
-
Clonidine withdrawal: Mechanism and frequency of rebound hypertension
-
Geyskes GG, Boer P, Dorhout-Mees EJ: Clonidine withdrawal: mechanism and frequency of rebound hypertension. Br J Clin Pharmacol 1979; 7:55-62
-
(1979)
Br J Clin Pharmacol
, vol.7
, pp. 55-62
-
-
Geyskes, G.G.1
Boer, P.2
Dorhout-Mees, E.J.3
-
51
-
-
0015408035
-
Propranolol and polythiazide in treatment of hypertension
-
O'Brien ET, MacKinnon J: Propranolol and polythiazide in treatment of hypertension. Br Heart J 1972; 34:1042-1044
-
(1972)
Br Heart J
, vol.34
, pp. 1042-1044
-
-
O'Brien, E.T.1
MacKinnon, J.2
-
52
-
-
0036245708
-
Discontinuation syndrome in dysthymic patients treated with selective serotonin-reuptake inhibitors: A clinical investigation
-
Bogetto F, Bellino S, Revello RB, et al: Discontinuation syndrome in dysthymic patients treated with selective serotonin-reuptake inhibitors: a clinical investigation. CNS Drugs 2002; 16:273-283
-
(2002)
CNS Drugs
, vol.16
, pp. 273-283
-
-
Bogetto, F.1
Bellino, S.2
Revello, R.B.3
-
53
-
-
0033899154
-
Selective serotonin-reuptake inhibitor discontinuation syndrome: Proposed diagnostic criteria
-
Black K, Shea C, Dursun S, et al: Selective serotonin-reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 2000; 25:255-261
-
(2000)
J Psychiatry Neurosci
, vol.25
, pp. 255-261
-
-
Black, K.1
Shea, C.2
Dursun, S.3
-
54
-
-
28444452940
-
Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder
-
Perahia DG, Kajdasz DK, Desaiah D, et al: Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder. J Affect Disord 2005; 89:207-212
-
(2005)
J Affect Disord
, vol.89
, pp. 207-212
-
-
Perahia, D.G.1
Kajdasz, D.K.2
Desaiah, D.3
-
55
-
-
33646799096
-
Prospective studies of adverse events related to antidepressant discontinuation
-
Fava M: Prospective studies of adverse events related to antidepressant discontinuation. J Clin Psychiatry 2006; 67 (suppl 4):14-21
-
(2006)
J Clin Psychiatry
, vol.67
, Issue.SUPPL. 4
, pp. 14-21
-
-
Fava, M.1
-
56
-
-
0029904001
-
A comparison of the post-marketing safety of four selective serotonin-reuptake inhibitors, including the investigation of symptoms occurring on withdrawal
-
Price JS, Waller PC, Wood SM, et al: A comparison of the post-marketing safety of four selective serotonin-reuptake inhibitors, including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 1996; 42:757-763
-
(1996)
Br J Clin Pharmacol
, vol.42
, pp. 757-763
-
-
Price, J.S.1
Waller, P.C.2
Wood, S.M.3
-
57
-
-
0032527557
-
Selective serotonin-reuptake inhibitor discontinuation syndrome: A randomized clinical trial
-
Rosenbaum JF, Fava M, Hoog SL, et al: Selective serotonin-reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 1998; 44:77-87
-
(1998)
Biol Psychiatry
, vol.44
, pp. 77-87
-
-
Rosenbaum, J.F.1
Fava, M.2
Hoog, S.L.3
-
58
-
-
0034167383
-
Interruption of selective serotonin-reuptake inhibitor treatment: Double-blind, placebo-controlled trial
-
Michelson D, Fava M, Amsterdam J, et al: Interruption of selective serotonin-reuptake inhibitor treatment: double-blind, placebo-controlled trial. Br J Psychiatry 2000; 176:363-368
-
(2000)
Br J Psychiatry
, vol.176
, pp. 363-368
-
-
Michelson, D.1
Fava, M.2
Amsterdam, J.3
-
59
-
-
0036738152
-
Discontinuation symptoms: Comparison of brief interruption in fluoxetine and paroxetine treatment
-
Judge R, Parry MG, Quail D, et al: Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. Int Clin Psychopharmacol 2002; 17:217-225
-
(2002)
Int Clin Psychopharmacol
, vol.17
, pp. 217-225
-
-
Judge, R.1
Parry, M.G.2
Quail, D.3
-
60
-
-
27544459825
-
Randomized trial of sertraline versus venlafaxine XR in major depression: Efficacy and discontinuation symptoms
-
Sir A, D'Souza RF, Uguz S, et al: Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms. J Clin Psychiatry 2005; 66:1312-1320
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 1312-1320
-
-
Sir, A.1
D'Souza, R.F.2
Uguz, S.3
-
61
-
-
0033764960
-
Abrupt and brief discontinuation of antidepressant treatment: Effects on cognitive function and psychomotor performance
-
Hindmarch I, Kimber S, Cockle SM: Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance. Int Clin Psychopharmacol 2000; 15:305-318
-
(2000)
Int Clin Psychopharmacol
, vol.15
, pp. 305-318
-
-
Hindmarch, I.1
Kimber, S.2
Cockle, S.M.3
-
62
-
-
33646762803
-
Antidepressant discontinuation syndrome: Consensus panel recommendations for clinical management and additional research
-
Schatzberg AF, Blier P, Delgado PL, et al: Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research. J Clin Psychiatry 2006; 67(suppl 4):27-30
-
(2006)
J Clin Psychiatry
, vol.67
, Issue.SUPPL. 4
, pp. 27-30
-
-
Schatzberg, A.F.1
Blier, P.2
Delgado, P.L.3
-
63
-
-
0030795390
-
Discontinuation symptoms after treatment with serotonin-reuptake inhibitors: A literature review
-
Zajecka J, Tracy KA, Mitchell S: Discontinuation symptoms after treatment with serotonin-reuptake inhibitors: a literature review. J Clin Psychiatry 1997; 58:291-297
-
(1997)
J Clin Psychiatry
, vol.58
, pp. 291-297
-
-
Zajecka, J.1
Tracy, K.A.2
Mitchell, S.3
-
65
-
-
33845989668
-
Antidepressant Discontinuation Syndrome: Current Perspectives and Consensus Recommendations for Management
-
Antidepressant Discontinuation Syndrome: Current Perspectives and Consensus Recommendations for Management. J Clin Psychiatry 2006; 67(suppl 4)
-
(2006)
J Clin Psychiatry
, vol.67
, Issue.SUPPL. 4
-
-
-
67
-
-
0141843501
-
Assessment and treatment of depression during pregnancy: An update
-
Nonacs R, Cohen LS: Assessment and treatment of depression during pregnancy: an update. Psychiatr Clin North Am 2003; 26:547-562
-
(2003)
Psychiatr Clin North Am
, vol.26
, pp. 547-562
-
-
Nonacs, R.1
Cohen, L.S.2
-
68
-
-
0032564904
-
Pregnancy outcome following maternal use of the new selective serotonin-reuptake inhibitors: A prospective, controlled multicenter study
-
Kulin NA, Pastuszak A, Sage SR, et al: Pregnancy outcome following maternal use of the new selective serotonin-reuptake inhibitors: a prospective, controlled multicenter study. JAMA 1998; 279:609-610
-
(1998)
JAMA
, vol.279
, pp. 609-610
-
-
Kulin, N.A.1
Pastuszak, A.2
Sage, S.R.3
-
69
-
-
85030522912
-
-
EPIP083 (Preliminary Report) Epidemiology Study: Preliminary Report on Bupropion in Pregnancy and the Occurrence of Cardiovascular and Major Congenital Malformations, 2005; accessed December 15, 2005, at http://ctr.gsk.co.uk/ summary/bupropion/studylist.asp
-
EPIP083 (Preliminary Report) Epidemiology Study: Preliminary Report on Bupropion in Pregnancy and the Occurrence of Cardiovascular and Major Congenital Malformations, 2005; accessed December 15, 2005, at http://ctr.gsk.co.uk/ summary/bupropion/studylist.asp
-
-
-
-
71
-
-
0029795224
-
Birth outcomes in pregnant women taking fluoxetine
-
Chambers CD, Johnson KA, Dick LM, et al: Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335:1010-1015
-
(1996)
N Engl J Med
, vol.335
, pp. 1010-1015
-
-
Chambers, C.D.1
Johnson, K.A.2
Dick, L.M.3
-
72
-
-
17644411089
-
Antidepressant use during pregnancy and the rates of spontaneous abortions: A metaanalysis
-
Hemels ME, Einarson A, Koren G, et al: Antidepressant use during pregnancy and the rates of spontaneous abortions: a metaanalysis. Ann Pharmacother 2005; 39:803-809
-
(2005)
Ann Pharmacother
, vol.39
, pp. 803-809
-
-
Hemels, M.E.1
Einarson, A.2
Koren, G.3
-
73
-
-
0033951163
-
Safety of fluoxetine during the first trimester of pregnancy: A metaanalytical review of epidemiological studies
-
Addis A, Koren G: Safety of fluoxetine during the first trimester of pregnancy: a metaanalytical review of epidemiological studies. Psychol Med 2000; 30:89-94
-
(2000)
Psychol Med
, vol.30
, pp. 89-94
-
-
Addis, A.1
Koren, G.2
-
74
-
-
0033530293
-
Pharmacologic treatment of depression during pregnancy
-
Wisner KL, Gelenberg AJ, Leonard H, et al: Pharmacologic treatment of depression during pregnancy. JAMA 1999; 282:1264-1269
-
(1999)
JAMA
, vol.282
, pp. 1264-1269
-
-
Wisner, K.L.1
Gelenberg, A.J.2
Leonard, H.3
-
75
-
-
11144358525
-
Neonate characteristics after maternal use of antidepressants in late pregnancy
-
Källén B: Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004; 158:312-316
-
(2004)
Arch Pediatr Adolesc Med
, vol.158
, pp. 312-316
-
-
Källén, B.1
-
77
-
-
1842866929
-
Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure
-
Oberlander TF, Misri S, Fitzgerald CE, et al: Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65:230-237
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 230-237
-
-
Oberlander, T.F.1
Misri, S.2
Fitzgerald, C.E.3
-
78
-
-
28444474891
-
Citalopram use in pregnancy: Prospective comparative evaluation of pregnancy and fetal outcome
-
Sivojelezova A, Shuhaiber S, Sarkissian L, et al: Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 2005; 193:2004-2009
-
(2005)
Am J Obstet Gynecol
, vol.193
, pp. 2004-2009
-
-
Sivojelezova, A.1
Shuhaiber, S.2
Sarkissian, L.3
-
79
-
-
13444252680
-
Selective serotonin-reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: A database analysis
-
Sanz EJ, De-las-Cuevas C, Kiuru A, et al: Selective serotonin-reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005; 365(9458):482-487
-
(2005)
Lancet
, vol.365
, Issue.9458
, pp. 482-487
-
-
Sanz, E.J.1
De-las-Cuevas, C.2
Kiuru, A.3
-
80
-
-
32244441984
-
Neonatal abstinence syndrome after in-utero exposure to selective serotonin-reuptake inhibitors in term infants
-
Levinson-Castiel R, Merlob P, Linder N, et al: Neonatal abstinence syndrome after in-utero exposure to selective serotonin-reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160:173-176
-
(2006)
Arch Pediatr Adolesc Med
, vol.160
, pp. 173-176
-
-
Levinson-Castiel, R.1
Merlob, P.2
Linder, N.3
-
81
-
-
32144436098
-
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn
-
Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al: Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354:579-587
-
(2006)
N Engl J Med
, vol.354
, pp. 579-587
-
-
Chambers, C.D.1
Hernandez-Diaz, S.2
Van Marter, L.J.3
-
82
-
-
0037399190
-
Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy
-
Casper RC, Fleisher BE, Lee-Ancajas JC, et al: Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003; 142:402-408
-
(2003)
J Pediatr
, vol.142
, pp. 402-408
-
-
Casper, R.C.1
Fleisher, B.E.2
Lee-Ancajas, J.C.3
-
83
-
-
0031022182
-
Neurodevelopment of children exposed in-utero to antidepressant drugs
-
Nulman I, Rovet J, Stewart DE, et al: Neurodevelopment of children exposed in-utero to antidepressant drugs. N Engl J Med 1997; 336:258-262
-
(1997)
N Engl J Med
, vol.336
, pp. 258-262
-
-
Nulman, I.1
Rovet, J.2
Stewart, D.E.3
-
84
-
-
85047697473
-
Internalizing behaviors in 4-year-old children exposed in-utero to psychotropic medications
-
Misri S, Reebye P, Kendrick K, et al: Internalizing behaviors in 4-year-old children exposed in-utero to psychotropic medications. Am J Psychiatry 2006; 163:1026-1032
-
(2006)
Am J Psychiatry
, vol.163
, pp. 1026-1032
-
-
Misri, S.1
Reebye, P.2
Kendrick, K.3
-
85
-
-
2942527162
-
Pooled analysis of anti-depressant levels in lactating mothers, breast milk, and nursing infants
-
Weissman AM, Levy BT, Hartz AJ, et al: Pooled analysis of anti-depressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 2004; 161:1066-1078
-
(2004)
Am J Psychiatry
, vol.161
, pp. 1066-1078
-
-
Weissman, A.M.1
Levy, B.T.2
Hartz, A.J.3
-
86
-
-
4444374093
-
A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate
-
Rampono J, Proud S, Hackett LP, et al: A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int J Neuropsychopharmacol 2004; 7:329-334
-
(2004)
Int J Neuropsychopharmacol
, vol.7
, pp. 329-334
-
-
Rampono, J.1
Proud, S.2
Hackett, L.P.3
-
87
-
-
5444248599
-
Breastfeeding during maternal antidepressant treatment with serotonin-reuptake inhibitors: Infant exposure, clinical symptoms, and cytochrome P450 genotypes
-
Berle JO, Steen VM, Aamo TO, et al: Breastfeeding during maternal antidepressant treatment with serotonin-reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome P450 genotypes. J Clin Psychiatry 2004; 65:1228-1234
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 1228-1234
-
-
Berle, J.O.1
Steen, V.M.2
Aamo, T.O.3
-
88
-
-
0742269637
-
Frequency of infant adverse events that are associated with citalopram use during breast-feeding
-
Lee A, Woo J, Ito S: Frequency of infant adverse events that are associated with citalopram use during breast-feeding. Am J Obstet Gynecol 2004; 190:218-221
-
(2004)
Am J Obstet Gynecol
, vol.190
, pp. 218-221
-
-
Lee, A.1
Woo, J.2
Ito, S.3
-
89
-
-
1542267722
-
Paroxetine during breast-feeding: Infant weight gain and maternal adherence to counsel
-
Merlob P, Stahl B, Sulkes J: Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel. Eur J Pediatr 2004; 163:135-139
-
(2004)
Eur J Pediatr
, vol.163
, pp. 135-139
-
-
Merlob, P.1
Stahl, B.2
Sulkes, J.3
-
90
-
-
1642577953
-
Treatment of depression in women: A summary of the expert consensus guidelines
-
Altshuler LL, Cohen LS, Moline ML, et al: Treatment of depression in women: a summary of the expert consensus guidelines. J Psychiatr Pract 2001; 7:185-208
-
(2001)
J Psychiatr Pract
, vol.7
, pp. 185-208
-
-
Altshuler, L.L.1
Cohen, L.S.2
Moline, M.L.3
-
91
-
-
0036787468
-
Management of major depression during pregnancy
-
Hendrick V, Altshuler L: Management of major depression during pregnancy. Am J Psychiatry 2002; 159:1667-1673
-
(2002)
Am J Psychiatry
, vol.159
, pp. 1667-1673
-
-
Hendrick, V.1
Altshuler, L.2
-
92
-
-
12344284587
-
The use of selective serotonin-reuptake inhibitors during pregnancy and breast-feeding: A review and clinical aspects
-
Hallberg P, Sjöblom V: The use of selective serotonin-reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. J Clin Psychopharmacol 2005; 25:59-73
-
(2005)
J Clin Psychopharmacol
, vol.25
, pp. 59-73
-
-
Hallberg, P.1
Sjöblom, V.2
-
93
-
-
7644238337
-
Relapse of depression during pregnancy following antidepressant discontinuation: A preliminary prospective study
-
Cohen LS, Nonacs RM, Bailey JW, et al: Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Archives of Women's Mental Health 2004; 7:217-221
-
(2004)
Archives of Women's Mental Health
, vol.7
, pp. 217-221
-
-
Cohen, L.S.1
Nonacs, R.M.2
Bailey, J.W.3
-
94
-
-
16244377094
-
Implications of antenatal depression and anxiety for obstetric outcome
-
Andersson L, Sundstrom-Poromaa I, Wulff M, et al: Implications of antenatal depression and anxiety for obstetric outcome. Obstet Gynecol 2004; 104:467-476
-
(2004)
Obstet Gynecol
, vol.104
, pp. 467-476
-
-
Andersson, L.1
Sundstrom-Poromaa, I.2
Wulff, M.3
-
95
-
-
0010551097
-
Depressive symptoms in parents of children under three: Sociodemographic predictors, current correlates, and associated parenting behaviors
-
Edited by Halfon N, Schuster M, Taaffe-Young K. New York, Cambridge University Press;
-
Lyons-Ruth K, Wolfe R, Lyubchik A, et al: Depressive symptoms in parents of children under three: sociodemographic predictors, current correlates, and associated parenting behaviors, in Child-Rearing in America: Challenges Facing Parents With Young Children. Edited by Halfon N, Schuster M, Taaffe-Young K. New York, Cambridge University Press; 2002, pp 217-262
-
(2002)
Child-Rearing in America: Challenges Facing Parents With Young Children
, pp. 217-262
-
-
Lyons-Ruth, K.1
Wolfe, R.2
Lyubchik, A.3
-
96
-
-
0026568290
-
The impact of postnatal depression on infant development
-
Murray L: The impact of postnatal depression on infant development. J Child Psychol Psychiatry 1992; 33:543-561
-
(1992)
J Child Psychol Psychiatry
, vol.33
, pp. 543-561
-
-
Murray, L.1
-
97
-
-
0035026947
-
Is there an association between selective serotonin-reuptake inhibitors and risk of abnormal bleeding? results from a cohort study based on prescription event monitoring in England
-
Layton D, Clark DW, Pearce GL, et al: Is there an association between selective serotonin-reuptake inhibitors and risk of abnormal bleeding? results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol 2001; 57:167-176
-
(2001)
Eur J Clin Pharmacol
, vol.57
, pp. 167-176
-
-
Layton, D.1
Clark, D.W.2
Pearce, G.L.3
|